Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Universal Health Services notched a solid second quarter and has raised its revenue guidance for the year, though it now expects earnings per share to drag due to individual facilities’ performance | Volume recovery, capacity increases, supplemental funding, some struggling facilities and a jump in liability expenses all played into a guidance revision at the acute and behavioral hospital operator. Health insurance exchange impacts, while elevated, still landed within the higher range of the company's initial expectations.
UHS beat Q2 ($4.64B +8.3%, $5.98 EPS) but cut full-year guidance to $22.28-23.65 due to facility headwinds and 7-9% professional cost inflation. ACA market pressure (-15% exchange patients) and cost escalation challenge legacy healthcare ops; Talkspace M&A signals industry pivot toward hybrid digital-care models.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

HCA Healthcare sent out a pre-earnings shockwave Tuesday morning with preliminary second-quarter results suggesting that coverage…

UPDATED: July 16 at 1 p.m. ET | UnitedHealth Group boosted its outlook for the year on the back of $5.5 billion in profit for the…

Community Health Systems fell short of the market’s earnings and revenue expectations during its second quarter, posting a loss…

Overperformances across each side of Tenet Healthcare’s business have allowed the company to escape Affordable Care Act health…

Alignment Health CEO John Kao is bullish about the company's continued growth, reiterating to investors that its strong revenue…

HCA Healthcare on Friday affirmed its early warni | The for-profit health system's executives said the number of patients who…